| Stock Price Performance - 12 Largest Negative Opening Gaps | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day of Event |
After Event Date (Not Including Day of Selected Event) |
||||||||||||||||
| Date | Note | Day-Of Move | Opening Gap | % Open-to-High | % Open-to-Low | Drift Open-to-Close | 1 Day | 2 Days | 3 Days | 1 Week | 2 Weeks | ||||||
| 26-Dec-2025 |
Press Release Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split (26-Dec-2025, 8:05 AM ACCESS Newswire) HeadlineAptevo Therapeutics announces 1-for-18 reverse stock split (26-Dec-2025, 12:00 AM Seeking Alpha News) |
-34.7% | |||||||||||||||
| 22-May-2025 |
Press Release Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split as part of Nasdaq Compliance Plan (22-May-2025, 8:10 AM ACCESS Newswire) |
-21.1% | |||||||||||||||
| 7-Apr-2025 | Market Gap DownSPY had a large negative gap on the day of -3.2% | -6.7% | |||||||||||||||
| 25-Mar-2025 | -22.8% | ||||||||||||||||
| 17-Sep-2024 |
Press Releases Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study (16-Sep-2024, 8:07 AM ACCESSWIRE) Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules (16-Sep-2024, 8:05 PM ACCESSWIRE) |
-38.0% | |||||||||||||||
| 24-Jul-2024 | -1.6% | ||||||||||||||||
| 18-Jul-2024 | -18.9% | ||||||||||||||||
| 28-Jun-2024 |
Press Release Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules (28-Jun-2024, 9:21 AM ACCESSWIRE) |
-40.6% | |||||||||||||||
| 17-Jun-2024 | -20.5% | ||||||||||||||||
| 11-Apr-2024 |
Press Releases Aptevo Therapeutics Provides Pipeline Update (10-Apr-2024, 9:03 AM ACCESSWIRE) Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering (11-Apr-2024, 8:01 AM ACCESSWIRE) |
-60.1% | |||||||||||||||
| 10-Nov-2023 | -24.0% | ||||||||||||||||
| 2-Aug-2023 |
Press Release Aptevo Therapeutics Inc. Announces Pricing of $5 Million Public Offering (1-Aug-2023, 10:15 PM ACCESSWIRE) |
-38.3% | |||||||||||||||
| Simple Average Returns - 12 Largest Negative Opening Gaps | |||||||||||||||||
| Avg Return | |||||||||||||||||
| Positive Occurrences | |||||||||||||||||
| Negative Occurrences | |||||||||||||||||
| Absolute Average Returns - 12 Largest Negative Opening Gaps | |||||||||||||||||
| Abs Avg Return | |||||||||||||||||
| Max Abs Return | |||||||||||||||||
| Min Abs Return | |||||||||||||||||
| Median, Minimum, and Maximum Returns - 12 Largest Negative Opening Gaps | |||||||||||||||||
| Median Return | |||||||||||||||||
| Max Positive Return | |||||||||||||||||
| Max Negative Return | |||||||||||||||||